Cargando…

Immune response to COVID-19 in older adults

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third highly pathogenic coronavirus to emerge in the human population in last two decades. SARS-CoV-2 spread from Wuhan, China, across the globe, causing an unprecedented public healthcare crisis. The virus showed remarkable age...

Descripción completa

Detalles Bibliográficos
Autores principales: Jergović, Mladen, Coplen, Christopher P., Uhrlaub, Jennifer L., Nikolich-Žugich, Janko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111884/
https://www.ncbi.nlm.nih.gov/pubmed/34140221
http://dx.doi.org/10.1016/j.healun.2021.04.017
_version_ 1783690582774775808
author Jergović, Mladen
Coplen, Christopher P.
Uhrlaub, Jennifer L.
Nikolich-Žugich, Janko
author_facet Jergović, Mladen
Coplen, Christopher P.
Uhrlaub, Jennifer L.
Nikolich-Žugich, Janko
author_sort Jergović, Mladen
collection PubMed
description The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third highly pathogenic coronavirus to emerge in the human population in last two decades. SARS-CoV-2 spread from Wuhan, China, across the globe, causing an unprecedented public healthcare crisis. The virus showed remarkable age dependent pathology, with symptoms resembling common cold in most adults and children while causing more severe respiratory distress and significant mortality in older and frail humans. Even before the SARS-CoV-2 outbreak infectious diseases represented one of the major causes of death of older adults. Loss of immune function and reduced protection from infectious agents with age – immunosenescence - is a result of complex mechanisms affecting production and maintenance of immune cells as well as the initiation, maintenance and termination of properly directed immune responses. Here we briefly discuss the current knowledge on how this process affects age-dependent outcomes of SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-8111884
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society for Heart and Lung Transplantation.
record_format MEDLINE/PubMed
spelling pubmed-81118842021-05-11 Immune response to COVID-19 in older adults Jergović, Mladen Coplen, Christopher P. Uhrlaub, Jennifer L. Nikolich-Žugich, Janko J Heart Lung Transplant Article The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third highly pathogenic coronavirus to emerge in the human population in last two decades. SARS-CoV-2 spread from Wuhan, China, across the globe, causing an unprecedented public healthcare crisis. The virus showed remarkable age dependent pathology, with symptoms resembling common cold in most adults and children while causing more severe respiratory distress and significant mortality in older and frail humans. Even before the SARS-CoV-2 outbreak infectious diseases represented one of the major causes of death of older adults. Loss of immune function and reduced protection from infectious agents with age – immunosenescence - is a result of complex mechanisms affecting production and maintenance of immune cells as well as the initiation, maintenance and termination of properly directed immune responses. Here we briefly discuss the current knowledge on how this process affects age-dependent outcomes of SARS-CoV-2 infection. International Society for Heart and Lung Transplantation. 2021-10 2021-05-11 /pmc/articles/PMC8111884/ /pubmed/34140221 http://dx.doi.org/10.1016/j.healun.2021.04.017 Text en © 2021 International Society for Heart and Lung Transplantation. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jergović, Mladen
Coplen, Christopher P.
Uhrlaub, Jennifer L.
Nikolich-Žugich, Janko
Immune response to COVID-19 in older adults
title Immune response to COVID-19 in older adults
title_full Immune response to COVID-19 in older adults
title_fullStr Immune response to COVID-19 in older adults
title_full_unstemmed Immune response to COVID-19 in older adults
title_short Immune response to COVID-19 in older adults
title_sort immune response to covid-19 in older adults
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111884/
https://www.ncbi.nlm.nih.gov/pubmed/34140221
http://dx.doi.org/10.1016/j.healun.2021.04.017
work_keys_str_mv AT jergovicmladen immuneresponsetocovid19inolderadults
AT coplenchristopherp immuneresponsetocovid19inolderadults
AT uhrlaubjenniferl immuneresponsetocovid19inolderadults
AT nikolichzugichjanko immuneresponsetocovid19inolderadults